Evaluation of renal effects of liposomal amphotericin B in children with malignancies with KDIGO and RIFLE criteria-Reference-Cited by-同舟云学术

Evaluation of renal effects of liposomal amphotericin B in children with malignancies with KDIGO and RIFLE criteria

Published:2021-12 Issue:7 Volume:17 Page:507-511
ISSN:1769-7255
Container-title:Néphrologie & Thérapeutique
language:en
Short-container-title:Néphrologie & Thérapeutique

Author:

Devrim Fatma,Çağlar İlknur,Acar Sultan Okur,Akkuş Şeyma,Dinçel Nida,Yılmaz Ebru,Tahta Neryal,Demirağ Bengü,Karapınar Tuba Hilkay,Gözmen Salih,Oymak Yeşim,Vergin Canan,Bayram Nuri,Devrim İlker

Publisher

Elsevier BV

Subject

Nephrology

Reference33 articles.

1. Pharmacology of systemic antifungal agents;Ashley;Clin Infec Dis,2006

2. Liposomal amphotericin B (AmBisome(®)): A review of the pharmacokinetics, pharmacodynamics, clinical experience and future directions;Stone;Drugs,2016

3. Current concepts in antifungal pharmacology;Lewis;Mayo Clin Proc,2011

4. Amphotericin B formulations: a comparative review of efficacy and toxicity;Hamill;Drugs,2013

5. Amphotericin B deoxycholate versus liposomal amphotericin B: effects on kidney function;Botero Aguirre;Cochrane Database Syst Rev,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic drug monitoring of liposomal amphotericin B in children. Are we there yet? A systematic review;Journal of Antimicrobial Chemotherapy;2024-01-22

2. Incidence of Antimicrobial-Associated Acute Kidney Injury in Children: A Structured Review;Pediatric Drugs;2023-12-13

3. Risk Factor Analysis of Vancomycin-Induced Nephrotoxicity in Paediatric Patients Aged 0–1 Year Using Japanese Medical Database;Biological and Pharmaceutical Bulletin;2023-06-01